Wassil Jim
Reporting owner on Forms 3, 4 and 5, CIK 1813798.
Wassil Jim reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-07.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PCVX · Vaxcyte, Inc.CIK 1649094 | officer (EVP, Chief Scientific Ofc, COO) | 2 | 2026-10-07 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PCVX · Vaxcyte, Inc.Common Stock | 2026-10-05 | M exercised | +18,000 | $5.35 | 163,435 | Form 4 |
| PCVX · Vaxcyte, Inc.Common Stock | 2026-10-05 | S sold | -18,000 | $86.74 | 145,435 | Form 4 |
| PCVX · Vaxcyte, Inc.Stock Option (right to buy), derivative | 2026-10-05 | M exercised | -18,000 | $0 | 46,398 | Form 4 |
| Vaxcyte, Inc. Common Stock | 2026-10-01 | M exercised | +2,250 | $5.35 | 147,685 | Form 4 |
| Vaxcyte, Inc. Common Stock | 2026-10-01 | S sold | -2,155 | $56.654 | 145,530 | Form 4 |
| Vaxcyte, Inc. Common Stock | 2026-10-01 | S sold | -95 | $57.094 | 145,435 | Form 4 |
| Vaxcyte, Inc. Stock Option (right to buy), derivative | 2026-10-01 | M exercised | -2,250 | $0 | 64,398 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001813798-26-000023 | Vaxcyte, Inc. | 2026-10-07 | ||
| Form 4 0001813798-26-000021 | Vaxcyte, Inc. | 2026-10-02 |